Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic value of MET, cyclin D1 and MET gene copy number in non-small cell lung cancer

1 Jan 2013

Abstract excerpt

The aim of this study was to analyze the correlation of the expression of MET and cyclin D1 and MET gene copy number in non-small cell lung cancer (NSCLC) tissues and patient clinicopathologic characteristics and survival. Sixty-one NSCLC tissue specimens were included in the study. The expression of MET and cyclin D1 was evaluated by immunohistochemistry and MET gene copy number was assessed by quantitative...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to Cholangiocarcinoma and Gallbladder Cancer Studies
Share to Liver physiology and pathology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23720678
DOI: 10.7555/jbr.27.20130004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic value of MET, cyclin D1 and MET gene copy number in non-small cell lung cancerPMID 23720678Read ↗

Met gene copy number predicts the prognosis for completely resected non-small cell lung cancer.Semantic proximity Read ↗

Correlation of MET gene amplification and TP53 mutation with PD-L1 expression in non-small cell lung cancerSemantic proximity Read ↗

MET expression and copy number heterogeneity in nonsquamous non-small cell lung cancer (nsNSCLC)Semantic proximity Read ↗

MET: a new promising biomarker in non-small-cell lung carcinoma.Semantic proximity Read ↗

MET and Small-Cell Lung CancerSemantic proximity Read ↗

Elucidation of the relationships of MET protein expression and gene copy number status with PD-L1 expression and the immune microenvironment in non-small cell lung cancer.Semantic proximity Read ↗

MET gene copy number gain is an independent poor prognostic marker in Korean stage I lung adenocarcinomas.Semantic proximity Read ↗

MET expression plays differing roles in non-small-cell lung cancer patients with or without EGFR mutation.Semantic proximity Read ↗

Clinicopathological characteristics of Non-Small Cell Lung Cancer (NSCLC) patients with c-MET exon 14 skipping mutation, MET overexpression and amplification.Semantic proximity Read ↗

MET Gene Amplification and Overexpression in Chinese Non-Small-Cell Lung Cancer Patients Without EGFR Mutations.Semantic proximity Read ↗

High MET gene copy number leads to shorter survival in patients with non-small cell lung cancer.Semantic proximity Read ↗

Prognostic and predictive value of MET deregulation in non-small cell lung cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.